Related by context. All words. (Click for frequent words.) 67 lactate dehydrogenase 66 histological subtype 65 CD4 + CD# 65 CD3 + 65 immunostaining 65 triiodothyronine 65 #ß 64 glutamyl 64 TNFalpha 64 isoenzyme 64 HepG2 cells 64 lymphocytosis 64 LPS induced 64 cathepsin B 64 VEGFR1 64 IFN g 64 Cytotoxic T 64 SGPT 63 cells μL 63 Foxp3 + 63 tryptase 63 interferon γ 63 leukocyte count 63 uM 63 bioavailable testosterone 63 phosphorylated tau 63 alanine aminotransferase ALT 63 normal karyotype 63 pDC 63 neutrophil count 63 plasma leptin 62 lactate dehydrogenase LDH 62 bFGF 62 bronchoalveolar lavage 62 Histologic 62 serum aminotransferase levels 62 histologic subtype 62 HOMA IR 62 lymphopenia 62 aspartate aminotransferase 62 alanine aminotransferase 62 leukocytosis 62 microvessel density 62 mRNA expression 62 prostaglandin E 62 mU liter 62 steroidogenic 62 Macrophage 62 seropositivity 62 Ribavirin causes 62 hematological parameters 62 transgene expression 62 PDGF B 62 gastric carcinoma 62 IFN γ 62 mRNA encoding 62 interleukin IL -6 62 adenosine diphosphate ADP 62 intravascular hemolysis 62 Insulin sensitivity 62 cisplatin resistant 61 Akt signaling 61 cell acute lymphoblastic 61 HER2 expression 61 CD# CD# 61 ERalpha 61 heterozygotes 61 hepatoma 61 Pharmacokinetics PK 61 TNF receptor 61 isoprostane 61 serum cortisol 61 serum calcium levels 61 Interferon gamma 61 J Am Soc 61 neutrophil counts 61 Secretase 61 Upregulation 61 factor HGF 61 nutlin 3a 61 IL 1ß 61 hemoglobin Hb 61 tumor xenograft models 61 homozygotes 61 Am J Cardiol 61 tumorigenicity 61 μg ml 61 extracellular signal 61 apo B 61 HLA DR 61 immunoreactivity 61 MLH1 61 PDGFR 61 Akt activation 61 monocyte 61 intercellular adhesion molecule 61 apolipoprotein B 61 CD#b 61 microglial 61 dehydroepiandrosterone sulfate 61 constitutively expressed 61 Kinoid 61 Immunohistochemical staining 61 angiopoietin 61 Th1 cells 61 μg liter 61 somatostatin 60 mediated inhibition 60 IGFBP 60 busulfan 60 vWF 60 intraperitoneally 60 lipoprotein Lp 60 HAQ DI 60 liver histology 60 p# activation 60 antibody mediated 60 TIMP 1 60 cTnI 60 IL 1β 60 log# copies mL 60 ALT elevation 60 murine model 60 haematologic 60 erythroid 60 ERK signaling 60 EGFR HER2 60 null mice 60 microglial activation 60 adrenoceptor 60 extramedullary 60 phosphate dehydrogenase 60 thymidine 60 Introgen ADVEXIN 60 CYP#A# CYP#D# 60 db db mice 60 achieved CCyR 60 â ‰ ¥ 60 μmol L 60 endothelial activation 60 thyroid carcinoma 60 HIF 1a 60 Leukemias 60 deoxy 60 H. influenzae 60 Crohn Disease Activity 60 relapsed MM 60 cell adhesion molecule 60 papillary renal cell carcinoma 60 cells uL 60 induced apoptosis 60 Extracellular 60 intratumoral 60 inhibin 60 TNF alpha IL 60 culture supernatants 60 JAK2 enzyme 60 monocyte chemoattractant protein 60 leukocyte counts 60 proapoptotic 60 plasminogen activator inhibitor 60 glycated hemoglobin levels 60 serum prostate 60 clonogenic 60 somatostatin analog 60 Multiple Myeloma MM 60 pathophysiological effects 60 corticosteroid dose 60 PSADT 60 HCV replicon 60 RRM1 60 Western blotting 60 humoral responses 60 biochemical relapse 60 p# alpha [001] 60 Fas ligand 60 Janus kinase 60 fluconazole resistant 60 TIMP 60 cardiac troponin 60 p# mitogen activated 60 Index CDAI 60 tumoral 60 HBeAg 60 CagA 60 Angiotensin converting enzyme 60 monocytic 60 inducible nitric oxide synthase 60 Leydig cell 59 Adrenergic 59 % Confidence Interval 59 hypoxia induced 59 CD# expression [002] 59 splice variants 59 monocytes macrophages 59 plasmacytoid 59 osteosarcomas 59 serum albumin 59 Eur J Endocrinol 59 syngeneic 59 5 hydroxytryptamine 59 serum triglycerides 59 univariate analysis 59 neutropenia dehydration dyspnea 59 CD#c 59 monocyte chemotactic protein 59 virologic responses 59 hepatocellular carcinomas 59 Serum concentrations 59 baseline LDH 59 NQO1 59 lumbar spine bone 59 bronchoalveolar lavage BAL 59 interleukin IL 59 SSc 59 ectopic expression 59 HLA DR4 59 % CI #.#-#.# [007] 59 peripheral blood mononuclear 59 HER2 overexpression 59 lymphocyte count 59 CLA isomers 59 c Fos 59 retinol binding protein 59 K ras mutations 59 hypothalamic pituitary 59 granzyme B 59 HBeAg seroconversion 59 airway hyperresponsiveness 59 hypereosinophilic syndrome 59 5 HT2A serotonin 59 CI #.#-#.# [001] 59 Primary endpoints 59 hepatic glucose production 59 ERK1 2 59 -#.# ± [002] 59 TRAIL induced apoptosis 59 elevated transaminases 59 dose dependently 59 osteoclastic 59 Tasigna prolongs 59 receptor inhibitor 59 CD# + [001] 59 aspartate aminotransferase AST 59 SGOT 59 hemagglutination inhibition HAI 59 response CCyR 59 Genotypic 59 thyrotropin 59 polymorphonuclear 59 rs# [004] 59 pT3 59 malignant neoplasm 59 potent inducer 59 ^ sup #m 59 nucleotide analog 59 colorectal carcinoma 59 Prognostic significance 59 differentially regulated 59 Factor Receptor 59 neoplastic 59 potently inhibited 59 GSTT1 59 leucopenia 59 miRNA expression 59 HOXB# 59 5 HT2C receptor 59 pharmacokinetic parameters 59 lymphocyte counts 59 chronic eosinophilic leukemia 59 inhibin B 59 xenograft tumors 59 grade squamous intraepithelial 59 Oncogenic 59 p# Shc 59 prostanoid 59 Flu Cy 59 C#BL 6 mice 59 selectively inhibited 59 CD# expression [001] 59 Amino acid 59 protein tyrosine kinase 59 intracellular Ca 2 59 overt nephropathy 59 CD8 T cell 59 CR nPR 59 FDG uptake 59 serum concentrations 59 immunohistochemical staining 59 cytopenias 59 enteroviral infection 59 colony stimulating factor 59 glutamic acid decarboxylase 59 STAT3 signaling 59 ^ sup + 59 Tumor Response 59 IgG antibody 59 replicon 59 Endometrial 59 prostate carcinoma 59 antitumor efficacy 59 Neutrophil 59 underlying vasculopathy 59 adipocyte 59 1alpha 59 #q# deletion syndrome 59 IFN gamma 59 colorectal adenocarcinoma 59 elastase 59 anti inflammatory cytokine 59 plasma triglycerides 59 ON #.Na 59 stimulated insulin secretion 59 Immunohistochemical analysis 59 virus HBV 59 ptau 59 muscarinic receptors 59 novel VDA molecule 59 Heterozygous 58 Cytogenetic 58 Cathepsin B 58 ara C 58 triacylglycerol 58 constitutively active 58 IL #p# 58 cytokeratin 58 carcinoembryonic antigen 58 cell receptor TCR 58 #.#/#.# mm Hg [003] 58 metastatic malignant 58 transgenic mice expressing 58 tissue transglutaminase 58 postprandial glycemia 58 degranulation 58 Immune responses 58 Cystatin C 58 selective agonist 58 CYP#A# substrate 58 CCyR 58 IGFBP 3 58 serum IGF 58 hydroxylase 58 serum HBV DNA 58 hepatic enzymes 58 plasma folate 58 BALB c mice 58 anti HBs 58 plasma cortisol 58 HBeAg negative 58 splenocytes 58 aminotransferase 58 thyroglobulin 58 CYP #D# 58 immunoblotting 58 #OHD 58 protein excretion 58 p = .# [002] 58 intact parathyroid hormone 58 plasma fibrinogen 58 hepatocellular carcinoma liver 58 metaplasia 58 serum phosphate 58 serum homocysteine 58 mitogen activated protein kinase 58 foveal thickness 58 HBeAg negative patients 58 lytic 58 urothelial carcinoma 58 upregulates 58 baseline CD4 58 inhibitory concentration 58 interleukin IL -# 58 mineralocorticoid 58 leukocyte 58 imatinib therapy 58 Thyroid hormone 58 HIF 1alpha 58 serine threonine 58 granulocyte 58 caveolin 1 58 glucuronide 58 maternal serum 58 5 HT1A receptor 58 matrix metalloproteinase 58 androgen receptor AR 58 fibrin deposition 58 albumin excretion rate 58 timepoints 58 Arch Intern Med 58 multivariate Cox 58 cytokines chemokines 58 Alanine 58 normoxic 58 E#F# 58 Ann Intern Med 58 exendin 4 58 morphometric vertebral fractures 58 alveolar epithelial cells 58 cytologic 58 coronary stenosis 58 protein tyrosine phosphatase 1B 58 explants 58 TGF β1 58 thyroid peroxidase 58 selective modulator 58 hemolytic 58 Secondary endpoints include 58 H#K#me# 58 lymphoid cells 58 serum bicarbonate 58 Ki# 58 preoperative PSA 58 adjunctive placebo 58 Supplementary Table 58 % CI #.#-#.# [003] 58 neurite outgrowth 58 fasting plasma 58 BCL2 58 MMP2 58 airway hyper responsiveness 58 p# MAPK 58 HIV HCV coinfected 58 blood glucose concentrations 58 variant allele 58 IL6 58 TRAIL R1 58 urinary cortisol 58 serum testosterone 58 troponin T 58 ceruloplasmin 58 TGF ß 58 glomerular filtration 58 MCF7 58 hyperplastic 58 Clusterin 58 serum leptin 58 pmol L 58 recurrent glioblastoma multiforme 58 monogenic 58 CCR7 58 effector function 58 Non inferiority 58 VEGF receptor 58 PEDF 58 plasma lipids 58 Protein Kinase C 58 induces apoptosis 58 siRNA knockdown 58 adrenocortical 58 IU ml 58 cytolytic 58 AT1R 58 antiproliferative activity 58 LRAT 58 methylenetetrahydrofolate reductase 58 antitrypsin 58 1α 58 colorectal tumor 58 urate oxidase 58 5alpha reductase 58 renal cell carcinomas 58 confidence intervals CIs 58 isomerase 58 activin 58 S#A# [002] 58 adrenocorticotropic hormone 58 eNOS 58 sitosterol 58 -#.# log# copies mL 58 HLA DRB1 * 58 JAK2 V#F 58 virological response 58 unconjugated 58 doxorubicin cyclophosphamide 58 colorectal adenoma 58 MSH2 58 CDK inhibitor 58 del 5q MDS 58 tipranavir ritonavir 58 Selective Inhibitor 58 umbilical artery 58 Leydig cells 58 E selectin 58 pancreatic endocrine 58 lumbar spine BMD 58 glucocorticoid induced 58 lymphoblasts 58 FASEB J. 58 myeloperoxidase 57 p = #.# [003] 57 huN# DM1 57 agonist induced 57 polymorphonuclear leukocytes 57 hypoxia inducible factor 57 serum lipid levels 57 immunological responses 57 T2DM 57 taxane resistant 57 effector memory 57 proteolysis 57 neuritic 57 Vidaza ® 57 receptor blocker 57 5HT 57 MCyR 57 nitrotyrosine 57 GSTP1 57 basophils 57 hepatic fibrosis 57 multivariable adjusted 57 plasmid encoding 57 recurrent venous thromboembolism 57 vasodilatation 57 metabolic parameters 57 antibody titer 57 FasL 57 PON1 57 downregulates 57 V#F mutation 57 dermatologic toxicities 57 Trichophyton rubrum 57 Overexpression 57 Acute myeloid leukemia 57 TNFα 57 REYATAZ r arm 57 P. acnes 57 HT 1A 57 C#BL/#J 57 pyrimidine 57 CYT# potent vascular disrupting 57 ± SEM 57 eosinophilia 57 aminotransferases 57 biologic DMARD 57 bone marrow lymph nodes 57 glomerular 57 HRCT 57 ,#,# [002] 57 BMPR2 57 Granulocyte Colony Stimulating Factor 57 pulmonary metastases 57 Postoperative complications 57 p#Kip# 57 radiosensitivity 57 Monocyte 57 pyrexia mucositis sepsis febrile 57 adipogenic 57 Platelet Derived Growth 57 Replikin 57 bronchoalveolar lavage fluid 57 #T# L1 57 creatine kinase MB 57 ligand TRAIL 57 pro angiogenic 57 antiphospholipid antibodies 57 osteoblast 57 cTnT 57 Endothelial 57 receptor monoclonal antibody 57 rFSH 57 PSA nadir 57 AST ALT 57 DLTs 57 leukotriene B4 57 aT cell 57 TC HDL 57 Aldosterone 57 demonstrated antitumor activity 57 immunopathology 57 microsomal 57 β actin 57 glyceraldehyde 3 57 steroidogenesis 57 vitro pharmacology 57 thromboxane A2 57 mutated K ras 57 clodronate 57 β1 57 complement inhibitor eculizumab 57 TGF ß1 57 ECOG PS 57 cytomegalovirus infection 57 cytidine 57 PC# cells 57 pyrimidines 57 Akt phosphorylation 57 IDDM 57 microvascular endothelial cells 57 myeloid derived 57 breast carcinomas 57 anemia hemoglobin 57 pleomorphic 57 leukocyte adhesion 57 promoter methylation 57 PTPN# 57 ug dose 57 Haptoglobin 57 parasitaemia 57 p# antigen 57 Free Full Text 57 p tau 57 vitro cytotoxicity 57 renal tubular 57 intraventricular hemorrhage 57 χ 57 vWD 57 serum antibody 57 serum urate levels 57 related apoptosis inducing 57 Hcy 57 enteroviral 57 invasive ductal 57 Ejection Fraction 57 postinjury 57 Supplemental Figure 57 LTB4 57 Stromal 57 ABL1 57 HIV RNA 57 arterial calcification 57 locomotor activity 57 hamartomas 57 Ph + acute lymphoblastic 57 #mg/day [002] 57 NMIBC 57 pg ml 57 #p# [003] 57 cells transfected 57 chloride secretion 57 experimental allergic encephalomyelitis 57 missense mutations 57 Rap1 57 VEGF expression 57 urine albumin 57 histologic findings 57 KLF4 57 fractional shortening 57 IgG1 57 nadolol 57 Histological 57 #:#-# [029] 57 glycosylated hemoglobin HbA1c 57 severe neutropenia 57 ASCUS 57 histone H3 lysine 57 MTT assay 57 neurologic progression 57 adiponectin concentrations 57 Papillary 57 Fibroblast 57 umbilical vein 57 pericardial effusion 57 IRE1 57 capillary density 57 aminotransferase levels 57 LNCaP cells 57 DR5 57 SMN1 57 eosinophil count 57 N. gonorrhoeae 57 biopsy Gleason 57 Subclinical 57 tissue oxygenation 57 mm ³ 57 GFAP 57 Tie2 57 BRAF V#E 57 plasma renin activity 57 serotonin norepinephrine 57 systemic amyloidosis 57 plasma pharmacokinetics 57 orally administered inhibitor 57 posttransplant 57 parasitemia 57 hepatocellular 57 mediated apoptosis 57 Kidney Int 57 potent inhibition 57 pmol liter 57 Polymorphisms 57 TNF α 57 nerve conduction velocity 57 erythrocyte sedimentation rate 57 inverse agonist 57 seminomas 57 intrahepatic 57 differentially expressed genes 57 serum HCV RNA 57 triggers apoptosis 57 Wistar rats 57 Streptococcus agalactiae 57 ERK pathway 57 urinary excretion 57 prospectively defined 57 F FDG PET 57 N methyl 56 #β estradiol 56 plasma lipid 56 hemodynamically significant 56 spirometric 56 myelofibrosis polycythemia vera 56 transcranial Doppler ultrasound 56 lopinavir r arm 56 induced sputum 56 Enzastaurin 56 Secondary endpoints included 56 FGF2 56 Vasopressin 56 semiquantitative 56 neutropaenia 56 intima media thickness 56 Glucocorticoids 56 Lupuzor ™ 56 N acetyl 56 HBV replication 56 fructosamine 56 GAPDH 56 inhibit replication 56 ALB # 56 pharmacodynamic PD 56 ^ Tc 56 BEXXAR Therapeutic Regimen 56 gliosis 56 TURBT 56 Superoxide 56 HCT# 56 factor PlGF 56 Plasma concentrations 56 ABCB1 56 soluble tumor necrosis 56 vasoactive 56 pancreatic alpha 56 Dysregulation 56 gadolinium enhancing 56 mL/min/#.# m 2 56 #:#-# [028] 56 intraabdominal 56 UGT#A# * 56 APOC3 56 chlamydial 56 hsCRP levels 56 selective antagonist 56 platelet reactivity 56 polyamine 56 RASSF1A 56 macrophage colony stimulating 56 2A receptor agonist 56 arteriolar 56 Proliferative 56 transfected cells 56 NS5B polymerase 56 immunohistochemical 56 mitogen 56 hyperoxaluria 56 LymphoStat B belimumab 56 % CI #.#-#.# [005] 56 pCR 56 sensory neuropathy 56 Beta Amyloid 56 Myelodysplastic Syndrome MDS 56 isoprostanes 56 myelin reactive T 56 endocannabinoid signaling 56 DAS# CRP 56 prostate cancer CaP 56 serum estradiol 56 PCWP 56 serum retinol 56 elevated ALT 56 Beta catenin pathway 56 phenotypic expression 56 κ 56 calculated creatinine clearance 56 CIN2 + 56 ischemia driven 56 fibrosarcoma 56 homozygote 56 subcutaneous immunoglobulin 56 lipoxygenase 56 MIC# [001] 56 experimentally induced 56 secondary efficacy endpoint 56 haematopoietic 56 prostate cancer PCa 56 FGFR4 56 ACh 56 Doxil ® 56 abacavir lamivudine 56 proto oncogene 56 alkaline phosphatase 56 HepG2 56 abnormal lymphocytes 56 lenalidomide Revlimid R 56 PBMCs 56 HepaLife PICM 56 oral squamous cell 56 MAP kinase 56 Abstract Number 56 Subtypes 56 tyrosine phosphorylation 56 fosbretabulin 56 FLT3 56 nanomolar 56 oral levofloxacin 56 ß1 56 azacytidine 56 autoregulation 56 transduced 56 ANCOVA 56 TUNEL 56 cytokine signaling 56 viral titers 56 evaluable subjects 56 left ventricular diastolic 56 endometrial thickness 56 nausea dehydration dyspnea 56 experimental autoimmune encephalomyelitis 56 Immunohistochemical 56 innate immune responses 56 specific alkaline phosphatase 56 E. faecalis 56 potent antitumor activity 56 metabolite concentrations 56 glucose insulin 56 leiomyoma 56 ovarian carcinoma 56 Health Assessment Questionnaire 56 Flt3 56 immunotoxicity 56 cyclic nucleotide 56 transcriptional silencing 56 MMSE score 56 Physical Component 56 colorectal carcinomas 56 PRADAXA #mg 56 TOP2A 56 Kupffer cells 56 gadolinium enhanced 56 hyperintensity 56 tumor necrosis 56 c MYC 56 telomere dysfunction 56 GCase 56 lysosomal 56 hyperhomocysteinemia 56 symptomatic intracranial hemorrhage 56 IGF binding 56 skeletal metastases 56 diphosphate 56 muscarinic 56 Catheter Associated 56 GABAergic interneurons 56 Foxp3 56 neovascular 56 isotypes 56 multivariable analysis 56 rheumatoid factor 56 linoleic acid LA 56 Osteopontin 56 J Clin Oncol 56 BARACLUDE ® 56 COPEGUS therapy 56 elevated LDH 56 phospholipase 56 CK MB 56 regulated kinase ERK 56 hTERT 56 generalized edema 56 urinary N telopeptide 56 methyltransferase 56 Factor VEGF 56 TMPRSS2 ERG 56 kidney allograft 56 actinin 56 macroalbuminuria 56 laboratory abnormalities 56 Cancer Res 56 lipid parameters 56 Treg cell 56 IPAH 56 coexpression 56 ^ sup ^ 56 Squamous 56 Modulates 56 hypermethylated 56 potently inhibit 56 LV ejection fraction 56 acromegalic patients 56 ischemia induced 56 IFN beta 56 generation antisense inhibitor 56 PI3K Akt 56 isoproterenol 56 basal bolus regimen 56 mediated immunity 56 IL#B 56 ANCA associated 56 erythrocyte 56 TrkB 56 potent cytotoxic 56 Echocardiographic 56 Corynebacterium 56 Hypotension 56 Gleevec resistant 56 proteoglycan 56 ug ml 56 differential gene expression 56 vimentin 56 capsular polysaccharide 56 methacholine challenge 56 paraneoplastic 56 PEG IFN 56 GHRH 56 RhuDex R 56 Legg Calvé Perthes disease 56 subscale scores 56 Mg Usa 56 HT 2A 56 Fig. 3b 56 acetylcholine receptor 56 integrin alpha 56 tyrosine hydroxylase 56 renal fibrosis 56 #.#/#.# mmHg [001] 56 complete cytogenetic response 56 Scale EDSS score 56 Gln 56 functional polymorphism 56 CD4 + cell 56 serum creatinine levels 56 Prolongs Survival 56 acute humoral rejection 56 mononuclear cells 56 selectively binds 56 % CI #.#-#.# [008] 56 sUA 56 pretransplant 56 alpha1 56 immunoglobulin G 56 NKX#.# 56 BCR ABL1 56 CI -#.# 56 Topoisomerase II 56 serum calcium 56 Heritability 56 neurofilament 56 apolipoproteins 56 J Natl Cancer Inst 56 STRIDE PD 56 nmol 56 PEGylated anti 56 Chronic HCV 56 Ischemic 56 CD# expressing 56 LRP5 56 hepatorenal syndrome 56 cefotaxime 56 cytotoxicity assays 56 lupus anticoagulant 56 pancreatic islet beta 56 56 murine models 56 serum urate 56 urothelial 56 Comorbidity 56 PGC 1α 56 extracapsular extension 56 NOD SCID mice 56 immunocompetent 56 CD4 + cells 56 radiographic findings 56 clinicopathological features 56 malondialdehyde MDA 56 cellularity 56 decarboxylase 56 recurrent VTE 56 annexin 56 #beta HSD1 56 downregulate 56 Platelet counts 55 iPTH 55 HLA DR4 immune 55 CD4 ^ sup 55 protein tyrosine phosphatase 55 -#.# mg dL [002] 55 corrected QT interval 55 Cyclin E 55 PDGF BB 55 Fibroblast Growth Factor 55 β blockers 55 CK # administered 55 reactogenicity 55 ß amyloid 55 clinicopathological 55 mean ± SEM 55 squamous intraepithelial lesions 55 tumor regressions 55 keratinocyte 55 intraperitoneal injection